Thousand Oaks biotech giant Amgen agreed to pay $24.75 million to settle claims by the U.S. Department of Justice that it illegally paid Medicare copays to encourage sales of two of its products. The kickbacks were allegedly paid through two foundations to cover copays for its hyperparathyroidism drug Sensipar and travel expenses for patients taking…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
